Hoo boy. That question gets us into the weeds very fast.

New Post Public Reply Private Reply Replies (1) Message Board
Rex Eupseiphos havasu78 #37368
1,073
Hoo boy. That question gets us into the weeds very fast. The short answer for why you get a very different p-value than they do is that the test you are using at Wolfram Alpha* begins to break down for small samples and collapses entirely when there are 0% or 100% fatalities. Near the bottom of the page they give a tiny little warning: "assuming two independent large simple random samples." The INDEPENDENT, LARGE, and RANDOM are all critical. If you have all three of those, it makes for easy statistics...just plug the numbers into an online calculator or dig out your Statistics 101 book from college or AP stats. Getting samples that are independent and random (or otherwise adequately representative) is actually pretty difficult in most cases, and it's one of things that they bend over backward trying to do in clinical trials. If your samples are bad, your statistics are garbage, no matter how good your models are. If you have small counts, it makes the modeling much more difficult.

In this case, Wolfram Alpha's test breaks down. Kiniksa uses some alternative, but they don't say what they did. A Fisher exact test gives 0.073 (don't let the name fool you, it ain't all that it's cracked up to be), which is close to what they got. In a different PR, they say p = 0.046 instead of 0.086, which looks suspiciously like a one-sided vs. two-sided test. Who knows for sure, but their number looks more reliable than Wolfram Alpha's because it gets (approximate) confirmation from the Fisher exact test.

I haven't seen any classical solution to the problem of modeling discrete counts with small means, so I usually jump into the Bayesian world for those. It is fairly easy to create robust and accurate Bayesian models for small counts, but it often amounts to writing custom models for a given problem, so you aren't likely to be able to find any online calculators to use or any plug-and-play formulas in Wikipedia or a textbook. However, there is a remarkably reliable approximation to a natural Bayesian solution: if you get all 0% survival (or mortality) for n patients, pretend like you got 1 mortality in 2n patients, and then use logistic regression for your test. I get about 0.02 for that test (one-sided). Or you can plug it into Wolfram Alpha and get 0.007 (which, again, is not great because of the small sample size).

A final caveat, ANY test with discrete random variables with a small mean will have difficulties because the discreteness means there are large probability gaps, and p-values will have only a finite---and most likely choppy---number of possible values, e.g., 0.0134, 0.0742, 0.186, 0.224, and so on with nothing to fill the gaps. But that being said, let's hope leronlimab has 0 fatalities in the s/c trial and 100% full recoveries in the m/m trials even if it makes their statisticians' jobs a little harder.


* search for "two binomial distribution test and use 0 for the "hypothesized parameter", which translates as "no difference between treatments" and is the natural null hypothesis

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hi3D Unlocks AI 3D Model for Open-Source Innovation

Updated Category News Views 4

A New Era in 3D Model Accessibility Unless you’ve been hiding under a rock, it’s hard to miss how digital terraforming has shifted gears. With Hi3D V1.0 opening its doors, the playing field's getting a major reshuffle. Or, as they say, the table is being set, and everyone's getting a seat. By letting loose production-validated AI tools, Hi3D is throwing down the...

Continue Reading
Full-Life's FL-020 Shows Promise for Prostate Cancer

Updated Category News Views 3

Breaking New Ground in Prostate Cancer Treatment You know, it’s not every day you stumble across news in the medical field that perks up the ears of investors, but let me tell ya, Full-Life Technologies' latest data drop has certainly caught my attention. If there’s even a smidge of truth in these findings, we might have a game-changer on our hands in the realm of...

Continue Reading
HawkEye 360 Expands with Advanced Satellite Launch

Updated Category News Views 4

Another Triumph for Signals Intelligence Launches come and go, but HawkEye 360's recent deployment of Cluster 16 isn't just another tick on their list. This satellite trio is kitted out with tech that propels the firm deeper into the realm of signals intelligence, where every second counts. The Art of Keeping Up with Demand Now, it's no simple feat to manage rocket...

Continue Reading
AHN Launches Cancer Screenings at Work; Dollar Bank First

Updated Category News Views 35

Pioneering Workplace Cancer Screening Initiative In a move that could redefine preventive healthcare, Allegheny Health Network (AHN) Cancer Center is taking cancer screenings right to the workplace. This initiative isn't just a new gimmick—it's a smart pivot in delivering healthcare where it's most convenient for employees. Here's looking at you, Dollar Bank, for being...

Continue Reading
Lowcountry Kids to Get Free Helmets at Safety Events

Updated Category News Views 1

Helmets for Kids Initiative Gets Rolling Now, here's a story that's more about community care than cash flow, but hey, sometimes even a grizzled trader like me can nod in appreciation. Christmas Injury Lawyers are putting their money where their mouth is, with the Helmets for Kids initiative staged at two key events in the Lowcountry area. Yep, that's right—the legal...

Continue Reading
VoxNexus Debuts On-Device AI: A Game-Changer for Languages

Updated Category News Views 0

VoxNexus Changes the Game with VoxEdge Here's the rub with tech: it often feels like it's only for the folks who already have a leg up. VoxNexus just flipped the script with its new product, VoxEdge, an on-device voice stack that's making waves by breaking language barriers in the ever-evolving AI world. This move might just shift the landscape of voice artificial...

Continue Reading
Corgi Invest Shakes Up Bond ETFs with Low Fees

Updated Category News Views 4

A Different Breed of Bond ETFs Well, folks, when you thought the ETF scene couldn't get any more crowded, Corgi Invest pops in with a pack of 14 new bond ETFs, barking up the low-expense tree like there's no tomorrow. They've dropped these puppies into the market with fees starting as low as 0.02%, aiming to take a bite out of their pricier rivals. The Alpha of Low-Cost...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 6

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 6

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Data Center Cooling Market to Hit $1B by 2033

Updated Category News Views 3

The Heat's On: Immersion Cooling Fluid Market Booms Kicking off with numbers straight out of the gate, data center immersion cooling fluids are gearing up for a wild ride. From just $0.23 billion back in 2026, this market is on a blitz to hit a whopping $1.06 billion by 2033. We're talking a hefty 24.8% compound annual growth rate. That's no small shakes. Race for Energy...

Continue Reading

Top 5 Most Recently Viewed Articles

United Therapeutics: Understanding Market Sentiment and Trends

Updated Category News Views 392

Market Sentiment Towards United Therapeutics United Therapeutics (NYSE: UTHR) has seen a notable increase in its short percent of float, rising to 7.82% since the last report. Currently, there are approximately 2.24 million shares sold short, equating to 6.62% of all regular shares available for trading. This trend indicates a growing cautious stance among some investors,...

Continue Reading
Canoe EIT Income Fund Reveals Monthly and Quarterly Distributions

Updated Category News Views 126

Canoe EIT Income Fund’s Distribution Announcements In the ever-evolving landscape of investment funds, the Canoe EIT Income Fund has made significant waves with its recent distribution announcements. The Fund, expertly managed and one of Canada’s premier closed-end investment opportunities, is prepared to offer a monthly distribution amounting to $0.10 per unit. This...

Continue Reading
ADMA Investors Evaluate Class Action Amidst Allegations

Updated Category News Views 9

Securities Fraud Allegations Cast Shadow Over ADMA Well, here we are again, wading through another mess in the biopharma world. This time, it's ADMA Biologics (NASDAQ: ADMA) in the spotlight, and not for their groundbreaking treatments. Nope, this one's about securities fraud allegations and, boy, do investors need to brace themselves. You got Berger Montague PC, those...

Continue Reading
Market Shifts: Navigating the Latest Trends in Trading

Updated Category News Views 266

Indices: An Overview of Uncertain Factors US equity index futures are stabilizing following a session marked by a remarkable rebound from previous lows, leading to higher closes for various indices. The S&P 500 rose by 0.4%, while the Nasdaq 100 surged up 0.7%, and the Dow 30 saw an increase of 0.5%. Notably, the small-cap Russell 2000 experienced the most significant...

Continue Reading
Primech A&P: A Trailblazer in Facility Management Excellence

Updated Category News Views 150

Primech A&P Achieves Prestigious Recognition in Facility Management With great pride, Primech Holdings Limited celebrates a significant milestone achieved by its subsidiary, Primech A&P Pte. Ltd. This notable recognition, the ASEAN Public Toilet Award, was presented in honor of Primech A&P's incredible management and upkeep of public facilities at Newton Food Centre....

Continue Reading